Skip to content

Quick ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.2×-0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-1.1×
AMP
Amphastar PharmaceuticalsAMPH
2.8×+0.8×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
1.6×+0.7×
CorMedix logo
CorMedixCRMD
2.7×-1.3×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
1.7×+0.7×

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's quick ratio?
Emergent Biosolutions (EBS) reported quick ratio of 2.1× in Q1 2026.
How has Emergent Biosolutions's quick ratio changed year-over-year?
Emergent Biosolutions's quick ratio decreased by 40.6% year-over-year, from 3.5× to 2.1×.
What is the long-term trend for Emergent Biosolutions's quick ratio?
Over 5 years (2020 to 2025), Emergent Biosolutions's quick ratio has grown at a 0.9% compound annual growth rate (CAGR), from 2.3× to 2.4×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.